LI, Yanmin, GOVADA, Lata, SOLOMON, Hodaya, GILLIS, Richard, ADAMS, Gary and CHAYEN, Naomi (2019). Analysis of Glulisine Crystallisation Utilising Phase Diagrams and Nucleants. Crystals, 9 (9): 462.
Documents
31139:611537
PDF
crystals-09-00462.pdf - Published Version
Available under License Creative Commons Attribution.
crystals-09-00462.pdf - Published Version
Available under License Creative Commons Attribution.
Download (1MB) | Preview
Abstract
Glulisine is a US Food and Drug Administration (FDA) approved insulin analogue, used for controlling hyperglycaemia in patients with diabetes mellitus (DM). It is fast acting which better approximates physiological insulin secretion, improving patient outcome. Crystallisation of Glulisine was analysed by its crystallisation phase diagram and nucleation-inducing materials. Both the hanging drop vapour diffusion and microbatch-under-oil methods were used and compared. We have shown that the same protein can have different solubility behaviours depending on the nature of the salt in the precipitating agent. In the case of Glulisine with magnesium formate, lowering the precipitant concentration drove the system further into supersaturation resulting in the formation of crystals and precipitation. This was the opposite effect to the usual scenario where raising the precipitant concentration leads to supersaturation. Glulisine with sodium potassium tartrate tetrahydrate (NaKT) followed the expected trend of forming crystals or precipitate at higher concentrations and clear drops at lower concentrations of the precipitant. The outcomes of crystallisation using the different crystallisation methods is also described. Glulisine was successfully crystallised and the crystals diffracted up to a resolution limit of 1.4 Å.
More Information
Statistics
Downloads
Downloads per month over past year
Metrics
Altmetric Badge
Dimensions Badge
Share
Actions (login required)
![]() |
View Item |